- Home
- DSGN vs CHOW Comparison
DSGN vs CHOW Comparison
Compare DSGN & CHOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- CHOW
- Stock Information
- Founded
- DSGN 2017
- CHOW 2014
- Country
- DSGN United States
- CHOW Hong Kong
- Employees
- DSGN N/A
- CHOW N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- CHOW Computer Software: Prepackaged Software
- Sector
- DSGN Health Care
- CHOW Technology
- Exchange
- DSGN Nasdaq
- CHOW Nasdaq
- Market Cap
- DSGN 208.9M
- CHOW 227.1M
- IPO Year
- DSGN 2021
- CHOW 2025
- Fundamental
- Price
- DSGN $6.24
- CHOW $8.18
- Analyst Decision
- DSGN
- CHOW
- Analyst Count
- DSGN 0
- CHOW 0
- Target Price
- DSGN N/A
- CHOW N/A
- AVG Volume (30 Days)
- DSGN 196.1K
- CHOW 467.1K
- Earning Date
- DSGN 11-07-2025
- CHOW 11-17-2025
- Dividend Yield
- DSGN N/A
- CHOW N/A
- EPS Growth
- DSGN N/A
- CHOW N/A
- EPS
- DSGN N/A
- CHOW 0.05
- Revenue
- DSGN N/A
- CHOW $23,409,092.00
- Revenue This Year
- DSGN N/A
- CHOW N/A
- Revenue Next Year
- DSGN N/A
- CHOW N/A
- P/E Ratio
- DSGN N/A
- CHOW $187.15
- Revenue Growth
- DSGN N/A
- CHOW 28.62
- 52 Week Low
- DSGN $2.60
- CHOW $4.00
- 52 Week High
- DSGN $7.77
- CHOW $21.91
- Technical
- Relative Strength Index (RSI)
- DSGN 49.22
- CHOW N/A
- Support Level
- DSGN $6.25
- CHOW N/A
- Resistance Level
- DSGN $6.77
- CHOW N/A
- Average True Range (ATR)
- DSGN 0.48
- CHOW 0.00
- MACD
- DSGN 0.02
- CHOW 0.00
- Stochastic Oscillator
- DSGN 49.74
- CHOW 0.00
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About CHOW ChowChow Cloud International Holdings Limited Ordinary Shares
ChowChow Cloud International Holdings Ltd is providing one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey from consulting, deployment and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment (ii) professional IT services comprising of capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations including infrastructure applications.